Table 2.

CHA2DS2-VASc score and initiated anticoagulant treatment in patients with newly diagnosed atrial fibrillation

VariableIntervention armControl arm
Screen-detected AF, N= 28Regularly detected AF, N= 95Regularly detected AF, N= 117
Mean CHA2DS2-VASc scorea (SD)3.6 (1.6)4.0 (1.5)3.9 (1.5)
CHA2DS2-VASc score 1, n (%)3 (10.7)6 (6.3)3 (2.6)
Female, n (%)15 (53.6)51 (53.7)71 (60.7)
CHA2DS2-VASc score 2 in females, n (%)0 (0.0)4 (7.8)8 (11.3)
Initiation of anticoagulant treatment,b n (%)
  VKA18 (64.3)45 (47.4)68 (58.1)
  NOAC5 (17.9)41 (43.2)34 (29.1)
  Antiplatelet0 (0.0)1 (1.1)4c (3.4)
Details about anticoagulant treatment, n (%)
  According to guidelinesd26 (92.9)89 (93.7)106 (90.6)
  Intended deviation from guidelinese1 (3.6)4 (4.2)5 (4.3)
  Unintended deviation from guidelinesf1 (3.6)2 (2.1)6 (5.1)
  • a CHA2DS2-VASc = Congestive heart failure (1 point); Hypertension (1 point); Age >75 years (2 points); Diabetes mellitus (1 point); Stroke including ischaemic stroke or transient ischaemic attack (2 points); Vascular disease including myocardial infarction, angina pectoris, coronary intervention, peripheral artery disease, arterial, or venous thrombosis (1 point); Age 65–75 years (1 point).

  • b Initiation of oral anticoagulant (OAC) treatment: some patients used OAC before diagnoses for mechanical heart valve or venous thromboembolism (VTE) (either lifelong prescription due to multiple VTE or temporary for recent first VTE); this was 2 for AF detection by screening, 4 for detection in usual care of intervention arm, and 4 for detection in control arm.

  • c Including two cases in whom either fragmin or clopidogrel was initiated.

  • d Treatment according to the Dutch College of General Practitioners guideline for patients treated in primary care and the European Society of Cardiologists guideline for patients treated in hospital.6,7

  • e Documented reason for deviation.

  • f No documented reason for deviation from guidelines. AF = atrial fibrillation. NOAC = novel oral anticoagulants. SD = standard deviation. VKA = vitamin K antagonists.